Literature DB >> 17516621

Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.

Ashley D Beall1, Paul J Nietert, Marian H Taylor, Holly C Mitchell, Stephanie R Shaftman, Richard M Silver, Edwin A Smith, Marcy B Bolster.   

Abstract

OBJECTIVE: To examine a cohort of patients with systemic sclerosis (SSc) and pulmonary hypertension (PH) for ethnic disparities in clinical presentation, disease detection, or management.
METHODS: Encounters of patients with SSc seen at the Medical University of South Carolina were recorded in a computerized database from November 1997 through January 2004. Patients were evaluated for discrepancy in disease manifestation and treatment. Evaluation criteria included patient ethnicity (by self report), age, disease duration from onset of first non-Raynaud's symptom, presence or absence of PH, incidence of diastolic dysfunction and left ventricular hypertrophy among patients with PH, severity of interstitial lung disease, and treatment course.
RESULTS: African Americans were more likely than Caucasians to have diffuse cutaneous SSc (dcSSc) (69.9% vs 42.9%, p < 0.001) and they presented with PH (defined as right ventricular systolic pressure > 40 mm Hg by echocardiogram or mean pulmonary artery pressure > 25 mm Hg by right heart catheterization (RHC) at a younger age (60.9 yrs vs 49.0 yrs, p < 0.001). There were no ethnic disparities in time from onset of the first non-Raynaud's symptom to detection of PH, method of PH detection, or treatment modalities. Patients with PH were more likely to have diastolic dysfunction than those without PH (52.3% vs 35.9%, p = 0.011).
CONCLUSION: In this cohort of patients, African Americans were more likely to have dcSSc. Among patients with PH, African Americans presented at a younger age than their Caucasian counterparts. Incidence of diastolic dysfunction was higher in the PH population. There were no significant ethnic disparities in time of progression to PH or in treatment modalities employed in our cohort.

Entities:  

Mesh:

Year:  2007        PMID: 17516621

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry.

Authors:  Mei-Sing Ong; Steve Abman; Eric D Austin; Jeffrey A Feinstein; Rachel K Hopper; Usha S Krishnan; Mary P Mullen; Marc D Natter; J Usha Raj; Erika B Rosenzweig; Kenneth D Mandl
Journal:  J Pediatr       Date:  2019-06-05       Impact factor: 4.406

2.  Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.

Authors:  Roozbeh Sharif; Marvin J Fritzler; Maureen D Mayes; Emilio B Gonzalez; Terry A McNearney; Hilda Draeger; Murray Baron; Daniel E Furst; Dinesh K Khanna; Deborah J del Junco; Jerry A Molitor; Elena Schiopu; Kristine Phillips; James R Seibold; Richard M Silver; Robert W Simms; Marilyn Perry; Carlos Rojo; Julio Charles; Xiaodong Zhou; Sandeep K Agarwal; John D Reveille; Shervin Assassi; Frank C Arnett
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

3.  Systemic Sclerosis and Pulmonary Disease.

Authors:  Khoa Ngo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia.

Authors:  Nevins W Todd; Sachin Lavania; Myung H Park; Aldo T Iacono; Teri J Franks; Jeffrey R Galvin; Jean Jeudy; Edward J Britt; Irina G Luzina; Jeffrey D Hasday; Sergei P Atamas
Journal:  J Heart Lung Transplant       Date:  2010-02       Impact factor: 10.247

5.  Pulmonary arterial capacitance predicts outcomes in patients with pulmonary hypertension independent of race/ethnicity, sex, and etiology.

Authors:  Jacob J Mayfield; Alexander Papolos; Elena Vasti; Teresa De Marco; Geoffrey H Tison
Journal:  Respir Med       Date:  2020-02-04       Impact factor: 3.415

6.  Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms.

Authors:  Hedwig Stanisz; Markus Seifert; Wolfgang Tilgen; Thomas Vogt; Knuth Rass
Journal:  Dermatoendocrinol       Date:  2011-10-01

7.  Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.

Authors:  Charles Reese; Beth Perry; Jonathan Heywood; Michael Bonner; Richard P Visconti; Rebecca Lee; Corey M Hatfield; Richard M Silver; Stanley Hoffman; Elena Tourkina
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

Review 8.  Racial differences between blacks and whites with systemic sclerosis.

Authors:  Richard M Silver; Galina Bogatkevich; Elena Tourkina; Paul J Nietert; Stanley Hoffman
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

9.  A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

Authors:  Virginia Steen; Robyn T Domsic; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2012-09

10.  Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.

Authors:  Rebecca Lee; Charles Reese; Beth Perry; Jonathan Heywood; Michael Bonner; Marina Zemskova; Richard M Silver; Stanley Hoffman; Elena Tourkina
Journal:  Fibrogenesis Tissue Repair       Date:  2015-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.